

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hiv infections | D015658 | EFO_0000764 | B20 | 3 | 2 | — | — | — | 5 |
| Infections | D007239 | EFO_0000544 | — | 1 | 1 | — | — | — | 2 |
| Communicable diseases | D003141 | — | — | 1 | 1 | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
| Renal insufficiency | D051437 | — | N19 | 1 | — | — | — | — | 1 |
| Drug common name | TENOFOVIR EXALIDEX |
| INN | tenofovir exalidex |
| Description | Tenofovir exalidex is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Small molecule |
| Drug class | antivirals |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CCCCCCCCCCCCCCCCOCCCOP(=O)(O)CO[C@H](C)Cn1cnc2c(N)ncnc21 |
| PDB | — |
| CAS-ID | 911208-73-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL515564 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | K7J545MEMA (ChemIDplus, GSRS) |
